Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.

Por Meier, J, Nüesch, E
Publicado em 1977

The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects.

Por Rüegg, P C, Nüesch, E
Publicado em 1987

Non-migrainous headache for the evaluation of oral analgesics

Por Graffenried, B. v., Nüesch, E.
Publicado em 1980

Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.

Por Hitzenberger, G, Fitscha, P, Beveridge, T, Nüesch, E, Pacha, W
Publicado em 1982

Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.

Por Aellig, W H, Nüesch, E, Engel, G, Grevel, J, Niederberger, W, Rosenthaler, J
Publicado em 1986

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data

Por Bohlius, J, Tonia, T, Nüesch, E, Jüni, P, Fey, M F, Egger, M, Bernhard, J
Publicado em 2014

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Por Gadgeel, S, Peters, S, Mok, T, Shaw, A T, Kim, D W, Ou, S I, Pérol, M, Wrona, A, Novello, S, Rosell, R, Zeaiter, A, Liu, T, Nüesch, E, Balas, B, Camidge, D R
Publicado no Ann Oncol (2018)